SEC Form 4 · accession 0001209191-18-060004
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kamalam Unninayar
Officer — Chief Financial Officer
Period of report
Nov 26, 2018
Accepted (ET)
Nov 27, 2018 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 26, 2018 | A | 18,469 | $0.00 | A | 18,469 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F3 | $3.79 | Nov 26, 2018 | A | 44,585 | A | — | Nov 26, 2028 | Common Stock, par value $0.01 per share | 44,585 | 44,585 | D |
Explanation of responses
- F1Represents a deferred stock award of restricted stock units which shall vest in four equal annual installments on January 1, 2019, 2020, 2021 and 2022.
- F2Includes a deferred stock award of 18,469 restricted stock units which vest in four equal annual installments on January 1, 2019, 2020, 2021 and 2022.
- F3This stock option vests in four equal annual installments on November 1, 2019, 2020, 2021 and 2022.
Remarks
This form has been signed under power of attorney.